Labels may affect decision-making for breast lesions

By Genevra Pittman NEW YORK (Reuters Health) – How doctors describe a non-invasive type of breast lesion may affect how women choose to have the abnormal cells treated, a new survey suggests. Ductal carcinoma in situ, or DCIS, accounts for about one in every five new breast cancer diagnoses in the United States when it’s included in cancer statistics. DCIS may spread and become invasive cancer, but is not life-threatening on its own – and some researchers question whether it should be called “cancer” at all. Still, most women with DCIS undergo breast-conserving surgery or a mastectomy. …